文献速递炎症性肠病消化内镜

成人克罗恩病上消化道受累的诊断与管理:系统综述

Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn's Disease: A Systematic Review.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-05-14

该系统综述检索Medline、Cochrane和Embase(1947年至2024年7月),纳入47篇文献,描述成人克罗恩病上消化道受累(UGICD)的患病率、临床表现及内科和外科管理。UGICD中位患病率为8.7%(四分位距4.74%-24.36%),超过三分之一患者无症状,内镜是最常用诊断工具(96%),抗肿瘤坏死因子治疗总体临床应答率为81%。

要点

  • UGICD中位患病率为8.7%(四分位距4.74%-24.36%)。
  • 超过三分之一UGICD患者无症状,有症状者腹痛最常见(41%;范围5%-93%)。
  • 内镜是最常用诊断工具(96%),十二指肠是最常见病变部位(69%)。

核心结论

  • 强调需要制定UGICD诊断和管理的标准化指导,本工作为UGICD管理的国际共识做准备。

研究设计与样本

  • 系统综述,检索Medline、Cochrane和Embase,纳入1947年至2024年7月发表的文献,最终纳入47篇文章,使用Joanna Briggs研究所清单进行质量评价。

主要发现

  • UGICD中位患病率为8.7%(四分位距4.74%-24.36%)。
  • 超过三分之一UGICD患者无症状,有症状患者中腹痛最常见(41%;范围5%-93%)。
  • 内镜是最常用诊断工具(96%),十二指肠是最常见病变部位(69%)。
  • 抗肿瘤坏死因子治疗对UGICD似乎有效(总体临床应答率81%)。
  • 各诊断 modality 内UGICD的公认定义尚未制定。

关键数值与推荐

  • UGICD中位患病率为8.7%(四分位距4.74%-24.36%)。
  • 有症状患者中腹痛发生率为41%(范围5%-93%)。
  • 内镜诊断使用率96%,十二指肠病变部位占69%。
  • 抗肿瘤坏死因子治疗总体临床应答率81%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 当前数据受研究之间研究设计和定义显著异质性限制,尤其是诊断和结局指标不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The diagnosis and management of ileocolonic Crohn's disease are well-established. In contrast, standardized guidance pertaining to the diagnosis and management of upper gastrointestinal Crohn's disease (UGICD) is lacking, despite its potentially severe consequences. This comprehensive systematic review describes the prevalence, clinical presentation, and medical and surgical management of involvement of the upper GI tract in adult patients with Crohn's disease. METHODS: A systematic review of available literature was conducted using the search engines Medline, Cochrane, and Embase, with pre-defined search algorithms. Studies published from 1947 to July 2024 were considered. The review included papers describing both clinical characteristics and the effectiveness of medical and interventional procedures in patients with UGICD. All included papers underwent quality appraisal using the Joanna Briggs Institute checklist. RESULTS: Following screening and full-text review, 47 articles were eligible. The median prevalence of UGICD was found to be 8.7% (interquartile range, 4.74%-24.36%). Over one-third of patients with UGICD are asymptomatic, and abdominal pain was the most frequently reported symptom in symptomatic patients (41%; range, 5%-93%). Endoscopy is the most used diagnostic tool (96%), with the duodenum being the most common disease location (69%). Accepted definitions of UGICD within each diagnostic modality have not been devised. Anti-tumor necrosis factor therapy appears to be efficacious for UGICD (overall clinical response, 81%). The current data are limited by the significant heterogeneity in study design and definitions between studies, particularly inconsistency in diagnosis and outcome measures used. CONCLUSIONS: We highlight the need for the development of standardized guidance in both diagnosing and managing UGICD. This work serves as preparation for an international consensus on the management of UGICD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Cohen NA, Sror N, Naseer M, et al. Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn's Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2025. PMID: 40378982. doi:10.1016/j.cgh.2025.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。